Agile Therapeutics Announces 1-For-40 Reverse Stock Split

Di: Ava

PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, About BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience.

Agile Therapeutics said late Monday its board approved a 1-for-50 reverse stock split, with a view to boosting the per-share trading price of the stock to satisfy the Nasdaq’s minimum-bid price Agile Therapeutics, Inc. (Nasdaq: NASDAQ: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current CAMBRIDGE, Mass. – Ernexa Therapeutics (NASDAQ:ERNA), a biotechnology company specializing in cell therapies for cancer and autoimmune diseases, has declared a reverse stock split of its common

Agile Therapeutics Stock Price & Overview

WeWork announces 1-for-40 reverse stock split to avoid getting kicked ...

Agile Therapeutics Announces 1-For-40 Reverse Stock Split PRINCETON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today announced that the Board approved a 1-for-40 reverse stock split, to be effective 5:00 p.m. on Tuesday, April 26, 2022. The Company’s common stock will open for

Cara Therapeutics announces a 1-for-12 reverse stock split effective December 30, 2024, to comply with Nasdaq requirements.

Stocks of the Day torm9f54666311pg396it2722217lA3lcr3a2f3iff2, · #Reverse_Split Agile Therapeutics Announces 1-For-40 Reverse Stock Split RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split June 13, 2025 SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel

PRINCETON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today announced that the Board approved a 1-for-40 reverse stock split, to be effective 5:00 p.m. on Tuesday, April 26, 2022. The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m The 1-for-40 reverse stock split will automatically convert 40 current shares of Agile’s common stock into one new share of common stock. No fractional shares will be issued in connection with

Agile Therapeutics Announces 1:50 Reverse Stock Split
CERo Therapeutics Announces 1-for-20 Reverse Stock Split
Agile Therapeutics, Inc. Latest Stock News
Channel Therapeutics Announces Reverse Common Stock Split

Commencing with the opening of trading on the Nasdaq Capital Market on October 2, 2024, the Company’s common stock will trade on a post-split basis under the same symbol ADTX.

Unicycive Therapeutics, Inc. Announces Reverse Stock Split

CERo Therapeutics Holdings (NASDAQ: CERO), an immunotherapy company, has announced a 1-for-20 reverse stock split effective June 13, 2025. The split will reduce outstanding common shares from approximately 10.3 million to 516,092. Trading on Nasdaq will begin on a split-adjusted basis on June 13, with a new CUSIP number 71902K402. The AGILE THERAPEUTICS ANNOUNCES 1-FOR-40 REVERSE STOCK SPLIT PRINCETON, N.J., April 26, 2022 – Agile Therapeutics, Inc. (Nasdaq: AGRX) („Agile“), a women’s healthcare company, today announced that the Board approved a 1-for-40 reverse stock split, to be effective 5:00 p.m. on Tuesday, April 26, 2022. PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“ Agile ”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday,

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today The reverse stock split was approved by Kintara’s stockholders at Kintara’s special meeting of stockholders held on October 4, 2024, to be effected in the Board’s discretion of not less than 1-for

Channel Therapeutics Corp. (CHRO) announced Friday a 10-for-1 reverse stock split in connection with the closing of its merger with Pelthos Therapeutics and a concurrent $50. The 1-for-50 reverse stock split will automatically convert 50 current shares of Agile’s common stock into one new share of common stock. No fractional shares will be issued in connection with the

WeWork announces 1-for-40 reverse stock split to avoid getting kicked ...

Agile Therapeutics, Inc. (Nasdaq: NASDAQ: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current

Tempest Therapeutics, Inc. (TPST), a pharmaceutical company with a market capitalization of $27.93 million, has announced a reverse stock split of its shares at a ratio of 1-for-13, effective from The 1-for-50 reverse stock split will automatically convert 50 current shares of Agile’s common stock into one new share of common stock. No fractional shares will be issued in connection with Free Stock Split Calendar 2025. Get the latest upcoming stock splits announcements in Nasdaq & NYSE, and explore recent & historical splits.

Agile Therapeutics Announces 1:50 Reverse Stock Split

PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“ Agile ”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday,

Get the latest Agile Therapeutics, Inc. (AGRX) stock price with news, financials and other important investing information. The 1-for-40 reverse stock split will automatically convert 40 current shares of Agile’s common stock into one new share of common stock. No fractional shares will be issued in connection with the reverse stock split. Stockholders who would otherwise hold a fractional share of Agile’s common stock will receive a cash payment in lieu thereof at a price equal to that

Channel Therapeutics Corporation announces a 10-for-one reverse stock split to increase share price and meet NYSE American listing requirements.

Channel Therapeutics (CHRO) announces a 10-for-1 reverse stock split effective July 1, 2025, ahead of a merger, $50M capital raise, and rebranding to Aditx Therapeutics (NASDAQ: ADTX) said on Friday that it intends to execute a 1-for-40 reverse stock split to regain compliance with the Nasdaq’s minimum bid price requirement. Agile Therapeutics, Inc. (Nasdaq: NASDAQ: AGRX) (“Agile”), a women’s healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current

Indaptus Therapeutics announces a one-for-twenty-eight reverse stock split effective June 27, 2025, to comply with Nasdaq requirements. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it will implement a 1-for-15 reverse stock split of

QQCWB

GV